Collaborative project for curation biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. It focuses on experimental evidence and plays with improved annotation of complexes and with the Evidence and Conclusion Ontology. The complexes link to EBI's Complex Portal, resulting from a collaboration with that database at the recent online ELIXIR biohackathon. Editing this pathway is (at this moment) coordinated via the wikipathways.slack.com #sarscov2 channel. Additionally, please feel free to add suggestions to the discussion page (see the tab at the top of this page). The large viral Spike protein (S or surface glycoprotein) forms trimers. It interacts with the host's ACE2 receptor to establish binding (Hoffmann et al 2020). There are suggestions for more than one cell entry mechanism, with the evidence for ACE2/TMPRSS2 entry being most clear now. Lack of expression of TMPRSS2 may explain age differences in COVID19 severity. In this mechanism, to enter the virus needs to be primed by the host protease TMPRSS2 that splits the Spike protein into 2 peptides S1 and S2. S1 contains the ACE2 receptor binding site, S2 binds to the host cell membrane which leads to membrane fusion, the start of the uptake process. The ACE2 receptor interaction was also suggested as the start of specific lung-damaging effects. Other human genes that may be involved in alternative cell uptake mechanisms include CTSL and SLC6A19.c4dHost translation inhibitor nsp1abfdb9d1ad44ad4af3bf9aa3aa3aa3aa3e1aaa3e1aaa3nsp3b94db2nsp10RdRpd8eef8b94Helicasensp14d8eNendoU2'-O-methyltransferaseaa3aa32'-O-methyltransferasensp10nsp3nsp10Host translation inhibitor nsp1e4ee63f49RdRpd8eef8b94abfc43d94bccf1bcc7c43c43d44cc7a1dc67b60f1bc43e63f49f1bbccd94d94c43f1bcc7e53c43c1fabff1baf3dd6b8faf3a7ad8fd8f[ECO_0005031]cc7[ECO_0005031]c43[ECO_0005031]bccf00c43[ECO_0005033]abfd94[ECO_0005031]bbb[ECO_0005031]c4332511376PubMedThe crystal structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine.bioRxiv2020PubMedPreprint: TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-1 CoV-2 in human airway epithelial cells and provide promising drug targets10.1101/2020.04.15.042085v1202032132184PubMedStructural basis for the recognition of the SARS-CoV-2 by full-length human ACE2.Science202032130973PubMedA potential role for integrins in host cell entry by SARS-CoV-2.Antiviral Res202033082293PubMedNeuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.Science202032489508PubMedSimultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?J Clin Med Res202032125455PubMedAngiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.Intensive Care Med202032706371PubMedPresence of Genetic Variants Among Young Men With Severe COVID-19.JAMA202032706371PubMedPresence of Genetic Variants Among Young Men With Severe COVID-19.JAMA202032680882PubMedStructural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.Science202033083157PubMedMutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load.PeerJ202032662421PubMedDoes the human placenta express the canonical cell entry mediators for SARS-CoV-2?Elife202032653452PubMedCharacterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.Antiviral Res2020disease by infectious agentDOID:0050117Disease32529116PubMedChemistry and Biology of SARS-CoV-2.Chem202032283108PubMedRemdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.Antiviral Res202032438371PubMedStructure of replicating SARS-CoV-2 polymerase.Nature202032938769PubMedThe Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.J Virol202033072893PubMedIdentification of novel mutations in themethyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.Biochem Biophys Rep202032169673PubMedGenetic evolution analysis of 2019 novel coronavirus and coronavirus from other species.Infect Genet Evol2020PubMedNeuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous systemhttps://doi.org/10.1101/2020.06.07.137802202032944968PubMedCholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.EMBO J202032321524PubMedEmerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.J Transl Med202032404436PubMedTMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.Sci Immunol202032592996PubMedCrystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.iScience202032376634PubMedCell entry mechanisms of SARS-CoV-2.Proc Natl Acad Sci U S A202032970989PubMedSARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.Cell202023943763PubMedSevere acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles.mBio201332142651PubMedSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.Cell202032917722PubMedSphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.J Biol Chem2020disease pathwayPW:0000013Pathway OntologyCOVID-19DOID:0080600Disease33244168PubMedHDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.Nat Metab202032159237PubMedFrom SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and non-structural genes.J Med Virol2020PubMedThe crystal structure of Nsp9 replicase protein of COVID-19https://www.ebi.ac.uk/pdbe/entry/pdb/6w4b202032155444PubMedStructure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.Cell2020PubMedhttps://www.youtube.com/watch?v=e2Qi-hAXdJo